McDermott’s +Dx Diagnostics Forum 2024 is the premier gathering of the laboratory diagnostics community.
BGL Managing Director Christoph Brandenberger will be a featured panelist for a session entitled, “Examining the Diagnostics Market: The View from Wall Street,” on Tuesday, September 24, from 9:10 a.m. to 9:40 a.m.
BGL’s Diagnostics, Research Tools & Medical Devices investment banking team has decades of experience advising companies across the diagnostics and device landscape. With this in-depth knowledge and background, we have provided capital formation, technology strategy, and medical device M&A strategy for a wide range of diagnostics, research tools, and device companies.